Home › Funds › Blue Chip Partners, LLC › ABT

Blue Chip Partners, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Blue Chip Partners, LLC reported holding 234,267 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$23.2M, representing 1.47% of its reported portfolio and ranking #28 among its reported holdings. Blue Chip Partners, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)234.27K sh
Reported value held$23.15M
Portfolio Weight1.47%
First reportedQ3 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Blue Chip Partners, LLC's ABT position evolved

Blue Chip Partners, LLC first disclosed a stake in ABT in Q3 2023 at 152,060 shares (US$14.7M). The position peaked in Q3 2025 at 201,876 shares, worth US$27.0M. Across 13 filings, Blue Chip Partners, LLC increased the stake 11 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 234,267 shares valued at US$23.2M — an increase of 10,194 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 152.06K $14.73M New
Q4 2023 145.42K $16.01M Reduce
Q1 2024 161.87K $18.40M Add
Q2 2024 172.69K $17.94M Add
Q3 2024 178.07K $20.30M Add
Q4 2024 179.47K $20.30M Add
Q1 2025 191.02K $25.34M Add
Q2 2025 194.73K $26.49M Add
Q3 2025 201.88K $27.04M Add
Q4 2025 206.40K $25.86M Add
Q1 2026 208.69K $21.43M Add
Q2 2026 224.07K $20.33M Add
Q3 2026 234.27K $23.15M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Blue Chip Partners, LLC held ABT?

Blue Chip Partners, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Blue Chip Partners, LLC's current position in ABT?

As of Q3 2026, Blue Chip Partners, LLC holds 234.27K shares of ABT (ABBOTT LABORATORIES), valued at $23.15M, representing 1.47% of its reported portfolio and ranking #28.

Has Blue Chip Partners, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Blue Chip Partners, LLC increased its position in ABT. The position peaked in Q3 2025 at 201.88K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.